A new treatment for endometrial cancer demonstrated strong potential in a Phase 3 clinical trial. Drugmaker Merck announced Monday that the investigational drug sacituzumab tirumotecan (sac-TMT) met ...

University of Iowa doctoral degree candidate Kaitriana Colling is paving the way for nonsurgical treatment for uterine cancer after the Iowa Cancer Registry found Iowa has the second highest rate of ...

Research led by a University of Iowa student is opening new doors to potential uterine cancer treatments that could allow patients to regain their health while retaining their ability to have children ...

Several factors cause women a delay in getting surgery to treat endometrial cancer. Some patients with endometrial cancer experience a delay in surgical treatment as a result of risk factors including ...

IOWA CITY, Iowa (IOWA CAPITAL DISPATCH) - Research led by a University of Iowa student is opening new doors to potential uterine cancer treatments that could allow patients to regain their health ...

Engagement in peer support sessions was associated with higher treatment completion and reduced early discontinuation, indicating adherence is modifiable beyond tumor biology and regimen intensity.

Trastuzumab pamirtecan (T-Pam) — a third-generation HER2-targeted antibody-drug conjugate — has substantial and durable antitumor activity in patients with previously treated HER2-expressing advanced ...

A University of Iowa student’s research is exploring new hormone therapies for uterine cancer. Five new progestins have shown more promise in lab tests than current clinical drugs. Her research helped ...